A next-generation of antivenom could be just around the corner. Besides being safer and more effective, the technology behind it can also be applicable for other diseases, such as cancer and COVID-19.
The Coca-Cola Company, one of the world’s largest producers of sugary beverages, has funded scientific research on fitness and public health at universities around the world. The newly-uncovered documents reveal that the money comes with strings attached. Five different funding agreements from universities show the company can prevent the results from going public, and has done so in the past. Similar concerns about conflicts of interest in commercially-funded research led to increasing funding disclosure requirements in science. However, researchers believe that this is probably not enough to assess the full extent of bias.Read more
Isn´t the sensation of being tickled just the most bizarre? As silly as it might seem, there is apparently a whole evolutionary war being waged in the process of tickling, according to studies.
- Protected: Which single-cell RNA sequencing data analysis tool to choose in 2022?August 17, 2022 - 8:46 am
- Best Electronic Lab Notebook (ELN) Review for Your Lab in 2021May 26, 2021 - 8:00 am
- The Next Generation Of Antivenom Production Holds Many Possibilities For The FutureMarch 17, 2021 - 8:19 am
- Connected Laboratory & the Role of IoT in ScienceFebruary 4, 2020 - 4:02 pm
- The Importance of Better Digital Data Management in Laboratories and The FAIR FutureFebruary 4, 2020 - 3:06 pm